Valproate (Depakote)

What it treats

Valproate is approved by the U.S. Food and Drug Administration for acute manic and mixed episodes in bipolar I disorder. It is also approved for certain seizure disorders and for migraine prevention. Prescribers often use it for maintenance in bipolar disorder, which is an off-label use in the strict labeling sense but common practice with strong evidence.

Where valproate really earns its keep is in acute mania. It works quickly compared with lithium, and it's a common choice when someone is admitted with a manic episode.

How it works

Valproate is an anticonvulsant that also stabilizes mood. It calms overactive nerve signaling in several ways at once. It raises the level of GABA, the brain's main calming chemical messenger. It also blocks sodium channels in nerve cells, which slows down excessive firing. There's a third effect that involves gene expression through what's called HDAC inhibition, and this is thought to matter for the mood-stabilizing side.

The full picture of how it steadies mood isn't known. What is clear in practice is that it works well for acute mania and helps prevent future episodes for many people.

Receptor mechanism (detail)

Valproate enhances GABAergic transmission, blocks voltage-gated sodium channels, and acts as a histone deacetylase (HDAC) inhibitor. That last effect, on gene expression, is thought to underlie the mood-stabilizing action that unfolds over weeks rather than days.

Potency and typical dosing pattern

Ranges are typical framework only, not a prescription for any individual.

Starting dose is roughly 15 to 20 mg/kg per day, divided. The dose is then adjusted based on a blood level. The target serum level is 50 to 125 micrograms/mL, with the higher end of that range (80 to 125) often needed for acute mania.

Divalproex ER can be dosed once daily. Immediate-release forms are usually split into two or three doses across the day.

Safety monitoring

• Serum valproate level (trough, drawn before the morning dose) to keep within 50 to 125 micrograms/mL.
• Liver function tests (LFTs) and CBC at baseline, at 1 month, then every 6 months.
• Ammonia if there's a change in mental status, confusion, or unexplained sedation. Valproate can raise ammonia without changing LFTs.
• Platelets, since valproate can lower them.
• Weight at every visit.
• Menstrual and reproductive history for patients who can become pregnant. Valproate is linked to polycystic ovary syndrome (PCOS) features and menstrual changes.
• Pregnancy status and highly effective contraception discussion at baseline and periodically.

What to expect

Valproate acts faster than lithium for mania. Some people feel their thinking start to slow within days at a therapeutic level. The steady mood-stabilizing effect builds over the following weeks.

Early side effects, if they show up, tend to arrive first: some stomach upset, sleepiness, or a mild tremor. Many of these settle as the body adjusts or as the dose is fine-tuned.

Common side effects

Most people get some side effects. The common ones include:

• Nausea or stomach upset, often best managed by taking it with food or by using the enteric-coated (Depakote) form.
• Sleepiness or fatigue.
• Weight gain over time.
• Tremor, usually mild and dose-related.
• Hair thinning, which is often helped by a zinc and selenium supplement.
• Mild dizziness.

If a side effect is severe, or it isn't improving after a few weeks, that's a conversation to have with the prescriber rather than a reason to stop on your own.

Serious side effects and warnings

Serious problems are uncommon, but the three main ones are important to understand.

Boxed warning. Valproate carries FDA boxed warnings for three serious problems. First, liver failure, which can be fatal and is most likely in the first six months of treatment and in young children. Second, pancreatitis, which can also be life-threatening and can happen at any time in treatment. Third, harm to a developing pregnancy, including neural tube defects and lasting effects on the child's IQ and behavior. Any severe abdominal pain, persistent vomiting, yellowing of the skin or eyes, dark urine, or unusual bleeding or bruising should be reported urgently.

• High ammonia. Valproate can raise blood ammonia even when LFTs look normal. Signs include confusion, sedation, tremor, or a sudden decline in thinking. This warrants an ammonia level and, if elevated, a change in plan.
• Low platelets. Valproate can drop the platelet count, sometimes enough to raise bleeding risk.
• PCOS features. Valproate is linked to polycystic ovary syndrome features in some patients: irregular periods, weight gain, acne, or excess hair growth. This is worth flagging early rather than dismissing.
• Suicidal thoughts. Like other anticonvulsants, valproate carries a warning about a possible small increase in suicidal thoughts. Any new or worsening thoughts of self-harm should prompt contact with the prescriber.

Sexual side effects

Valproate isn't a leading cause of sexual side effects the way SSRIs and SNRIs often are. Some people report reduced desire or erectile difficulties, and hormonal changes can play a part. If sexual function shifts after starting it, that's worth raising with the prescriber.

Weight, appetite, and sleep

Weight gain is one of valproate's better-known long-term effects. It's often gradual and can be significant over months to years. Talking about eating patterns and activity early on, rather than after twenty pounds, tends to work better.

Appetite may increase. Sleep effects go both ways: many people feel more sedated, especially early on, while some notice their sleep quality actually improves as mania settles.

Starting and dosing basics

This section is general background, not a dosing instruction for any individual. The right dose and form are decisions for a prescriber.

Valproate comes as several forms: valproic acid (Depakene), divalproex sodium delayed-release (Depakote), divalproex extended-release (Depakote ER), and sprinkle capsules. The forms aren't interchangeable milligram for milligram, and the ER form is dosed once daily while others are usually split.

Blood levels guide dosing. A level is typically checked about 5 days after any dose change, drawn as a trough just before the morning dose.

Missed doses and interactions

If you miss a dose, take it when you remember unless it's close to the next scheduled dose. Don't double up.

Several interactions matter. Valproate raises lamotrigine levels significantly, so lamotrigine has to be titrated even more slowly when the two are combined. Aspirin can raise the free (active) fraction of valproate. Carbamazepine and other enzyme inducers lower valproate levels. Valproate itself is broadly inhibitory of some liver enzymes and can raise levels of other drugs.

Alcohol isn't formally prohibited, but it's a bad match: it adds to liver strain, sedation, and sleep disruption. Give every prescriber and pharmacist a full list of your medications and supplements, including over-the-counter ones.

Stopping and tapering

Stopping valproate should be gradual and planned with a prescriber. An abrupt stop can destabilize mood and, in people with a seizure history, raise seizure risk. A step-down over weeks is the safer approach.

Pregnancy and breastfeeding

This is where valproate stands apart from the other mood stabilizers. It carries a boxed warning for teratogenicity: it raises the risk of neural tube defects (spina bifida), craniofacial defects, and lasting reductions in the child's IQ and higher-risk of autism spectrum and ADHD in exposed children. For people who can become pregnant, valproate isn't a first choice, and highly effective contraception is expected if it's used.

Anyone who is pregnant, planning a pregnancy, or breastfeeding should talk it through with their prescriber urgently so alternatives can be considered.

Cost and generic availability

Valproate has been available as a generic for many years and is inexpensive. Brand names include Depakote, Depakote ER, and Depakene. Generic divalproex and generic valproic acid contain the same active medication and work the same way. The extended-release form may cost more than the delayed-release form.

Common questions

How fast does valproate work for mania? Faster than lithium in many cases. Some people notice mania settling within days at a therapeutic level, though the fuller effect builds over one to two weeks.

Why do I need blood tests? A serum level guides the dose. LFTs and CBC catch the rare but serious problems (liver injury and blood count changes) early. Ammonia is checked if thinking suddenly changes.

Can I take it if I might become pregnant? Usually not as a first choice. Valproate raises the risk of birth defects and lasting cognitive effects on the child. If it's the only option that works, contraception has to be reliable and the conversation has to happen with the prescriber up front.

Does it cause weight gain? For many people, yes. It's often gradual. Talking about eating patterns and activity early tends to work better than waiting.

Is it addictive? No. Valproate doesn't cause cravings or compulsive use. The body does adjust to it, which is why stopping should be gradual.

Questions to ask your prescriber

• What are we hoping this treats, and how will we know it's working?
• What lab tests do I need, and how often?
• If I can become pregnant, is valproate really the best choice for me?
• Which side effects should I call you about right away?
• If we decide to stop it later, how would we do that safely?

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes, and current as of June 8, 2026.

• U.S. Food and Drug Administration. Divalproex sodium (Depakote) and valproic acid (Depakene) prescribing information.
• MedlinePlus, U.S. National Library of Medicine. Valproic acid.
• National Institute of Mental Health. Mental health medications.
• American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder.
• National Institute for Health and Care Excellence (NICE). CG185, Bipolar disorder: assessment and management.
• International Society for Bipolar Disorders (ISBD). Consensus statements on mood stabilizers.